Have a personal or library account? Click to login
Recent Updates on Acquired Hepatocerebral Degeneration Cover

Recent Updates on Acquired Hepatocerebral Degeneration

Tremor and Other Hyperkinetic Movements
Volume 7 (2017): Issue 0
By: Hae-Won Shin and  Hee Kyung Park  
Open Access
|Sep 2017

References

  1. 1
    VictorMAdamsRDColeMThe acquired (non-Wilsonian) type of chronic hepatocerebral degenerationMedicine (Baltimore)196544345396doi: http://dx.doi.org/10.1097/00005792-196509000-000015318075
    Back to article
  2. 2
    PinarbasiBKalymakogluSMaturZAkyuzFDemirKBesisikFAre acquired hepatocerebral degeneration and hepatic myelopathy reversible?J Clin Gastroenterol200943176181doi: http://dx.doi.org/10.1097/MCG.0b013e318150d39918698265
    Back to article
  3. 3
    Fernandez-RodriguezRContrerasAde VilloriaJGGrandasFAcquired hepatocerebral degeneration: clinical characteristics and MRI findingsEur J Neurol20101714631470doi: http://dx.doi.org/10.1111/j.1468-1331.2010.03076.x20491897
    Back to article
  4. 4
    QaviAHHammadSRanaAISalihMShahNHDarFSReversal of acquired hepatocerebral degeneration with living donor liver transplantationLiver Transpl201622125129doi: http://dx.doi.org/10.1002/lt.2430626283624
    Back to article
  5. 5
    BurkhardPRDelavelleJDu PasquierRSpahrLChronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degenerationArch Neurol200360521528doi: http://dx.doi.org/10.1001/archneur.60.4.52112707065
    Back to article
  6. 6
    StracciariAMattarozziKD'AlessandroRBaldinEGuarinoMCognitive functioning in chronic acquired hepatocerebral degenerationMetab Brain Dis200823155160doi: http://dx.doi.org/10.1007/s11011-008-9088-318437544
    Back to article
  7. 7
    MethawasinKChonmaitreePWongjitratCRattanamongkolgulSAsawavichienjindaTMovement Disorders in Non-Wilsonian Cirrhotic Patients: A Report of the Prevalence and Risk Factors from a Study Done in a Medical School in an Agricultural-Based CommunityJ Mov Disord201692834doi: http://dx.doi.org/10.14802/jmd.1503426648181
    Back to article
  8. 8
    KlosKJAhlskogJEJosephsKAFealeyRDCowlCTKumarNNeurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicityArch Neurol20056213851390doi: http://dx.doi.org/10.1001/archneur.62.9.138516157745
    Back to article
  9. 9
    ScaglioneSKliethermesSCaoGShohamDDurazoRLukeAThe Epidemiology of Cirrhosis in the United States: A Population-based StudyJ Clin Gastroenterol201549690696doi: http://dx.doi.org/10.1097/MCG.000000000000020825291348
    Back to article
  10. 10
    TrycABGoldbeckerABerdingGRümkeSAfsharKShahrezaeiGHCirrhosis-related Parkinsonism: prevalence, mechanisms and response to treatmentsJ Hepatol201358698705doi: http://dx.doi.org/10.1016/j.jhep.2012.11.04323220368
    Back to article
  11. 11
    KangJHTsaiMCLinCCLinHLLinHCIncreased risk of Parkinsonism among patients with cirrhosis: a 7-year follow-up studyLiver Int201131685691doi: http://dx.doi.org/10.1111/j.1478-3231.2010.02432.x21457440
    Back to article
  12. 12
    FerraraJJankovicJAcquired hepatocerebral degenerationJ Neurol2009256320332doi: http://dx.doi.org/10.1007/s00415-009-0144-719224314
    Back to article
  13. 13
    JogMSLangAEChronic acquired hepatocerebral degeneration: case reports and new insightsMov Disord199510714722doi: http://dx.doi.org/10.1002/mds.8701006048749990
    Back to article
  14. 14
    ButterworthRFMetal toxicity, liver disease and neurodegenerationNeurotox Res201018100105doi: http://dx.doi.org/10.1007/s12640-010-9185-z20369313
    Back to article
  15. 15
    FinlaysonMHSupervilleBDistribution of cerebral lesions in acquired hepatocerebral degenerationBrain19811047995doi: http://dx.doi.org/10.1093/brain/104.1.797470846
    Back to article
  16. 16
    ButterworthRNeuronal cell death in hepatic encephalopathyMetab Brain Dis200722309320doi: http://dx.doi.org/10.1007/s11011-007-9072-317851742
    Back to article
  17. 17
    Kleinschmidt-DeMastersBKFilleyCMRojianiAMOverlapping features of extrapontine myelinolysis and acquired chronic (non-Wilsonian) hepatocerebral degenerationActa Neuropathol2006112605616doi: http://dx.doi.org/10.1007/s00401-006-0112-616871403
    Back to article
  18. 18
    LeeJLacomisDComuSJacobsohnJKanalEAcquired hepatocerebral degeneration: MR and pathologic findingsAJNR Am J Neuroradiol1998194854879541303
    Back to article
  19. 19
    HathoutLHuangJZamaniAMoriokaCEl-SadenSWhite matter changes in chronic alcoholic liver disease: Hypothesized association and putative biochemical mechanismsMed Hypotheses201585825834doi: http://dx.doi.org/10.1016/j.mehy.2015.10.00226474927
    Back to article
  20. 20
    RoseCFVerkhratskyAParpuraVAstrocyte glutamine synthetase: pivotal in health and diseaseBiochem Soc Trans20134115181524doi: http://dx.doi.org/10.1042/BST2013023724256247
    Back to article
  21. 21
    ZwingmannCButterworthRAn update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopyNeurochem Int2005471930doi: http://dx.doi.org/10.1016/j.neuint.2005.04.00315916833
    Back to article
  22. 22
    ButterworthRFPathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisitedMetab Brain Dis20163112111215doi: http://dx.doi.org/10.1007/s11011-015-9746-126521983
    Back to article
  23. 23
    Pomier-LayrarguesGSpahrLButterworthRFIncreased manganese concentrations in pallidum of cirrhotic patientsLancet1995345735doi: http://dx.doi.org/10.1016/S0140-6736(95)90909-5
    Back to article
  24. 24
    HauserRAZesiewiczTARosemurgyASMartinezCOlanowCWManganese intoxication and chronic liver failureAnn Neurol199436871875doi: http://dx.doi.org/10.1002/ana.4103606117998773
    Back to article
  25. 25
    ButterworthRFSpahrLFontaineSLayrarguesGPManganese toxicity, dopaminergic dysfunction and hepatic encephalopathyMetab Brain Dis199510259267doi: http://dx.doi.org/10.1007/BF021093578847990
    Back to article
  26. 26
    ChenPChakrabortySMukhopadhyaySLeeEPaolielloMMBowmanABManganese homeostasis in the nervous systemJ Neurochem2015134601610doi: http://dx.doi.org/10.1111/jnc.1317025982296
    Back to article
  27. 27
    HuangEOngWYConnorJRDistribution of divalent metal transporter-1 in the monkey basal gangliaNeuroscience2004128487496doi: http://dx.doi.org/10.1016/j.neuroscience.2004.06.05515381278
    Back to article
  28. 28
    PeresTVSchettingerMRChenPCarvalhoFAvilaDSBowmanAB“Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies”BMC Pharmacol Toxicol20161757doi: http://dx.doi.org/10.1186/s40360-016-0099-027814772
    Back to article
  29. 29
    LechpammerMCleggMSMuzarZHuebnerPAJinLWGospeSMJrPathology of inherited manganese transporter deficiencyAnn Neurol201475608612doi: http://dx.doi.org/10.1002/ana.2413124599576
    Back to article
  30. 30
    ParkJSBlairNFSueCMThe role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanismsMov Disord201530770779doi: http://dx.doi.org/10.1002/mds.2624325900096
    Back to article
  31. 31
    WrightGSwainMAnnaneDSalibaFSamuelDArroyoVNeuroinflammation in liver disease: sessional talks from ISHENMetab Brain Dis20163113391354doi: http://dx.doi.org/10.1007/s11011-016-9918-727726053
    Back to article
  32. 32
    SmitaBGafoorVASaifudheenKJoseJAcute stroke-like presentation of acquired hepatocerebral degenerationAnn Indian Acad Neurol201417204206doi: http://dx.doi.org/10.4103/0972-2327.13263125024574
    Back to article
  33. 33
    GleasonAHayhowBWalterfangMEvansAMocellinRGatesPNeuropsychiatric symptoms as the presenting feature of acquired hepatocerebral degenerationAust N Z J Psychiatry201448959960doi: http://dx.doi.org/10.1177/000486741453107924740250
    Back to article
  34. 34
    SalehiSDShawcrossDLReversal of acquired hepatocerebral degeneration with living donor liver transplantationLiver Transpl201622693doi: http://dx.doi.org/10.1002/lt.2442326919380
    Back to article
  35. 35
    StracciariABaldinECretellaLDelajLD'AlessandroRGuarinoMChronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestationsNeurol Sci201132411415doi: http://dx.doi.org/10.1007/s10072-011-0481-z21328073
    Back to article
  36. 36
    KimJMKimJSJeongSHKimYKKimSEKimSHDopaminergic neuronal integrity in parkinsonism associated with liver cirrhosisNeurotoxicology201031351355doi: http://dx.doi.org/10.1016/j.neuro.2010.05.00220457180
    Back to article
  37. 37
    ParkHKKimSMChoiCGLeeMCChungSJEffect of trientine on manganese intoxication in a patient with acquired hepatocerebral degenerationMov Disord200823768770doi: http://dx.doi.org/10.1002/mds.2195718307260
    Back to article
  38. 38
    ZamanQAhmadAKhokarNKhanMFBilateral ballismus as a presenting feature of acquired hepatocerebral degenerationParkinsonism Relat Disord201625104105doi: http://dx.doi.org/10.1016/j.parkreldis.2016.02.01426923522
    Back to article
  39. 39
    ParkSAHeoKProminent cerebellar symptoms with unusual magnetic resonance imaging findings in acquired hepatocerebral degenerationArch Neurol20046114581460doi: http://dx.doi.org/10.1001/archneur.61.9.145815364694
    Back to article
  40. 40
    MelzerNGrimmAMeuthSGSolymosiLStollGA pure cerebellar syndrome with corresponding ponto-cerebellar atrophy in acquired hepatocerebral degenerationJ Neurol Sci20102929698doi: http://dx.doi.org/10.1016/j.jns.2010.02.02220233618
    Back to article
  41. 41
    MendezMFHepatic dementia or acquired hepatocerebral degenerationJ Am Geriatr Soc198937259260doi: http://dx.doi.org/10.1111/j.1532-5415.1989.tb06817.x2918197
    Back to article
  42. 42
    MaffeoEMontuschiASturaGGiordanaMTChronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patientsNeurol Sci201435523530doi: http://dx.doi.org/10.1007/s10072-013-1458-x23712371
    Back to article
  43. 43
    RenjenPNKhannaLRastogiRKhanNIAcquired hepatocerebral degenerationBMJ Case Rep20132013doi: http://dx.doi.org/10.1136/bcr-2013-009387
    Back to article
  44. 44
    GhysCKongMFGlibertGLasserLKarmaliRA lady with NASH and choreoathetosisActa Clin Belg201570375376doi: http://dx.doi.org/10.1179/2295333715Y.000000002726278630
    Back to article
  45. 45
    CampelloneJVLacomisDGiulianiMJKrobothFJHepatic myelopathy. Case report with review of the literatureClin Neurol Neurosurg199698242246doi: http://dx.doi.org/10.1016/0303-8467(96)00018-28884097
    Back to article
  46. 46
    UtkuUAsilTBalciKUzuncaICelikYHepatic myelopathy with spastic paraparesisClin Neurol Neurosurg2005107514516doi: http://dx.doi.org/10.1016/j.clineuro.2004.10.00216202825
    Back to article
  47. 47
    MendozaGMarti-FabregasJKulisevskyJEscartinAHepatic myelopathy: a rare complication of portacaval shuntEur Neurol199434209212doi: http://dx.doi.org/10.1159/0001170408082679
    Back to article
  48. 48
    BandmannOWeissKHKalerSGWilson's disease and other neurological copper disordersLancet Neurol201514103113doi: http://dx.doi.org/10.1016/S1474-4422(14)70190-525496901
    Back to article
  49. 49
    PalPKSamiiACalneDBManganese neurotoxicity: a review of clinical features, imaging and pathologyNeurotoxicology19992022723810385886
    Back to article
  50. 50
    FerenciPCacaKLoudianosGMieli-VerganiGTannerSSternliebIDiagnosis and phenotypic classification of Wilson diseaseLiver Int200323139142doi: http://dx.doi.org/10.1034/j.1600-0676.2003.00824.x12955875
    Back to article
  51. 51
    DamasioJRamosCMirandaHMagalhaesMAcquired hepatocerebral degeneration and Wilson's disease: Differential diagnosisMovement Disord200924S400S400
    Back to article
  52. 52
    KlosKJAhlskogJEKumarNCambernSButzJBurrittMBrain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensityNeurology20066719841989doi: http://dx.doi.org/10.1212/01.wnl.0000247037.37807.7617159105
    Back to article
  53. 53
    MaedaHSatoMYoshikawaAKimuraMSonomuraTTeradaMBrain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brainNeuroradiology199739546550doi: http://dx.doi.org/10.1007/s0023400504649272489
    Back to article
  54. 54
    PujolAPujolJGrausFRimolaAPeriJMercaderJMHyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failureNeurology1993436569doi: http://dx.doi.org/10.1212/WNL.43.1_Part_1.658423913
    Back to article
  55. 55
    KulisevskyJPujolJJunqueCDeusJBalanzoJCapdevilaAMRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration?Neurology19934325702573doi: http://dx.doi.org/10.1212/WNL.43.12.25708255459
    Back to article
  56. 56
    PujolAGrausFPeriJMercaderJMRimolaAHyperintensity in the globus pallidus on T1-weighted and inversion-recovery MRI: a possible marker of advanced liver diseaseNeurology19914115261527doi: http://dx.doi.org/10.1212/WNL.41.9.15261891111
    Back to article
  57. 57
    SaitoHEjimaALiver dysfunction and probable manganese accumulation in the brainstem and basal gangliaJ Neurol Neurosurg Psychiatry199558760761doi: http://dx.doi.org/10.1136/jnnp.58.6.760-a
    Back to article
  58. 58
    NagappaMSinhaSSainiJSKallolimathPSinghNKumarANon-Wilsonian hepatolenticular degeneration: Clinical and MRI observations in four families from south IndiaJ Clin Neurosci2016279194doi: http://dx.doi.org/10.1016/j.jocn.2015.06.03526765764
    Back to article
  59. 59
    CersosimoMGKollerWCThe diagnosis of manganese-induced parkinsonismNeurotoxicology200627340346doi: http://dx.doi.org/10.1016/j.neuro.2005.10.00616325915
    Back to article
  60. 60
    SungJHKimCYYangSOKhangHSCheongHKLeeJSChanges in blood manganese concentration and MRI t1 relaxation time during 180 days of stainless steel welding-fume exposure in cynomolgus monkeysInhal Toxicol2007194755doi: http://dx.doi.org/10.1080/0895837060098583417127642
    Back to article
  61. 61
    SpahrLButterworthRFFontaineSBuiLTherrienGMilettePCIncreased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptomsHepatology19962411161120doi: http://dx.doi.org/10.1002/hep.5102405238903385
    Back to article
  62. 62
    LayrarguesGPShapcottDSpahrLButterworthRFAccumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy?Metab Brain Dis199510353356doi: http://dx.doi.org/10.1007/BF021093658847998
    Back to article
  63. 63
    KimYNeuroimaging in manganismNeurotoxicology200627369372doi: http://dx.doi.org/10.1016/j.neuro.2005.12.00216442160
    Back to article
  64. 64
    RavinaBEidelbergDAhlskogJEAlbinRLBrooksDJCarbonMThe role of radiotracer imaging in Parkinson diseaseNeurology200564208215doi: http://dx.doi.org/10.1212/01.WNL.0000149403.14458.7F15668415
    Back to article
  65. 65
    CummingsJLHenchcliffeCSchaierSSimuniTWaxmanAKempPThe role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegenerationBrain201113431463166doi: http://dx.doi.org/10.1093/brain/awr17721810889
    Back to article
  66. 66
    NikolausSAntkeCKleyKPoeppelTDHautzelHSchmidtDInvestigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humansRev Neurosci20071843947218330212
    Back to article
  67. 67
    WeissenbornKBerdingGKostlerHAltered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathyMetab Brain Dis20001517317811206586
    Back to article
  68. 68
    MousseauDDPerneyPLayrarguesGPButterworthRFSelective loss of pallidal dopamine D2 receptor density in hepatic encephalopathyNeurosci Lett1993162192196doi: http://dx.doi.org/10.1016/0304-3940(93)90593-A8121627
    Back to article
  69. 69
    KimJKimJMKimYKShinJWChoiSHKimSEDopamine transporter SPECT of a liver cirrhotic with atypical parkinsonismInd Health200745497500doi: http://dx.doi.org/10.2486/indhealth.45.49717634700
    Back to article
  70. 70
    KimYKimJMKimJWYooCILeeCRLeeJHDopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?Mov Disord200217568575doi: http://dx.doi.org/10.1002/mds.1008912112209
    Back to article
  71. 71
    PeresTVParmaleeNLMartinez-FinleyEJAschnerMUntangling the Manganese-alpha-Synuclein WebFront Neurosci201610364doi: http://dx.doi.org/10.3389/fnins.2016.0036427540354
    Back to article
  72. 72
    RacetteBANielsenSSCriswellSRSheppardLSeixasNWardenMNDose-dependent progression of parkinsonism in manganese-exposed weldersNeurology201788344351doi: http://dx.doi.org/10.1212/WNL.000000000000353328031394
    Back to article
  73. 73
    JankovicJSearching for a relationship between manganese and welding and Parkinson's diseaseNeurology20056420212028doi: http://dx.doi.org/10.1212/01.WNL.0000166916.40902.6315985567
    Back to article
  74. 74
    PowersKMSmith-WellerTFranklinGMLongstrethWTJrSwansonPDCheckowayHParkinson's disease risks associated with dietary iron, manganese, and other nutrient intakesNeurology20036017611766doi: http://dx.doi.org/10.1212/01.WNL.0000068021.13945.7F12796527
    Back to article
  75. 75
    IshiiKShioyaAFukudaKMoriKTamaokaAAcquired hepatocerebral degeneration with middle cerebellar peduncles lesions: case report and review of the literatureClin Neurol Neurosurg201211413611364doi: http://dx.doi.org/10.1016/j.clineuro.2012.03.03222551581
    Back to article
  76. 76
    FurukawaRSakakibaraRHosoeNKishiMOgawaESuzukiYAtaxia and middle cerebellar peduncle lesions in hepatic encephalopathyNeuroradiology200951273274doi: http://dx.doi.org/10.1007/s00234-009-0515-x19259655
    Back to article
  77. 77
    IwasaMMifuji-MorokaRKurodaMMorokaHFujitaNKobayashiYRegional reduction in gray and white matter volume in brains of cirrhotic patients: voxel-based analysis of MRIMetab Brain Dis201227551557doi: http://dx.doi.org/10.1007/s11011-012-9314-x22618586
    Back to article
  78. 78
    ChenHJZhuXQShuHYangMZhangYDingJStructural and functional cerebral impairments in cirrhotic patients with a history of overt hepatic encephalopathyEuropean J Radiol20128124632469doi: http://dx.doi.org/10.1016/j.ejrad.2011.10.00822056487
    Back to article
  79. 79
    MelzerNGrimmAMeuthSGSolymosiLStollGA pure cerebellar syndrome with corresponding ponto-cerebellar atrophy in acquired hepatocerebral degenerationJ Neurol Sci20102929698doi: http://dx.doi.org/10.1016/j.jns.2010.02.02220233618
    Back to article
  80. 80
    ZhangLJQiRZhongJXuQZhengGLuGMThe effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry studyPloS One20127e42824doi: http://dx.doi.org/10.1371/journal.pone.004282422912746
    Back to article
  81. 81
    ErroRVitaleCPicilloMBaronePPellecchiaMTEarly MRI findings in acquired hepatocerebral degenerationNeurol Sci201334589591doi: http://dx.doi.org/10.1007/s10072-012-1087-922526762
    Back to article
  82. 82
    KreisRRossBDFarrowNAAckermanZMetabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopyRadiology19921821927doi: http://dx.doi.org/10.1148/radiology.182.1.13457601345760
    Back to article
  83. 83
    TarasówEPanasiukASiergiejczykLOrzechowska-BobkiewiczALewszukAWaleckiJMR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathyHepatogastroenterology2003502149215314696484
    Back to article
  84. 84
    LongLLLiXRHuangZKJiangYMFuSXZhengWRelationship between changes in brain MRI and (1)H-MRS, severity of chronic liver damage, and recovery after liver transplantationExp Biol Med (Maywood)200923410751085doi: http://dx.doi.org/10.3181/0903-RM-11819546351
    Back to article
  85. 85
    PowellEEPenderMPChalkJBParkinPJStrongRLynchSImprovement in chronic hepatocerebral degeneration following liver transplantationGastroenterology19909810791082doi: http://dx.doi.org/10.1016/0016-5085(90)90036-Z2311862
    Back to article
  86. 86
    ShulmanLMMinagarAWeinerWJReversal of parkinsonism following liver transplantationNeurology200360519doi: http://dx.doi.org/10.1212/WNL.60.3.51912578945
    Back to article
  87. 87
    ChenYHaqueMYoshidaEMTransient improvement of acquired hepatocerebral degeneration with parkinsonian symptoms after failed liver transplant: case report and literature reviewExp Clin Transplant2011936336922142042
    Back to article
  88. 88
    PapapetropoulosSSingerCManagement of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD)Mov Disord20052010881089doi: http://dx.doi.org/10.1002/mds.2058515954132
    Back to article
  89. 89
    Servin-AbadLTzakisASchiffERRegevAAcquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantationLiver Transpl20061211611165doi: http://dx.doi.org/10.1002/lt.2081516799948
    Back to article
  90. 90
    ButterworthRFParkinsonism in cirrhosis: pathogenesis and current therapeutic optionsMetab Brain Dis201328261267doi: http://dx.doi.org/10.1007/s11011-012-9341-723086199
    Back to article
  91. 91
    DejongCHvan de PollMCSoetersPBJalanROlde DaminkSWAromatic amino acid metabolism during liver failureJ Nutr20071371579S1585Sdiscussion 1597S–1598S17513430
    Back to article
  92. 92
    FukuiHSaitoHUenoYUtoHObaraKSakaidaIEvidence-based clinical practice guidelines for liver cirrhosis 2015Journal Gastroenterol201651629650doi: http://dx.doi.org/10.1007/s00535-016-1216-y
    Back to article
  93. 93
    UekiYIsozakiEMiyazakiYKoideRShimizuTYagiKClinical and neuroradiological improvement in chronic acquired hepatocerebral degeneration after branched-chain amino acid therapyActa Neurol Scand2002106113116doi: http://dx.doi.org/10.1034/j.1600-0404.2002.01230.x12100372
    Back to article
  94. 94
    HisaharaSMatsushitaTKitamuraMMezawaSNonakaMImaiTLong-term clinical and radiological improvement of chronic acquired hepatocerebral degeneration after obliteration of portosystemic shunt: Report of a caseJ Neurol Sci2014346303306doi: http://dx.doi.org/10.1016/j.jns.2014.07.06825172193
    Back to article
DOI: https://doi.org/10.5334/tohm.379 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Mar 11, 2017
Accepted on: Jul 24, 2017
Published on: Sep 5, 2017
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Acquired hepatocerebral degeneration,
liver cirrhosis,
manganese,
parkinsonism,
neuroinflammation,
dopamine transporter imaging

© 2017 Hae-Won Shin, Hee Kyung Park, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 7 (2017): Issue 0Next article